Company news
Syntheticmr Ab (NGM:SYNT) news
Syntheticmr Ab news releases on 6ix. Latest, Aug 25, 2026: SyntheticMR: Interim report April – June 2026
Press releases & updates
SyntheticMR: Interim report April – June 2026
August 25, 2026
SYNT: Sales fell 8% but losses narrowed; recurring revenue and cash position improved
May 12, 2026
SyntheticMR publishes Annual Report for 2025
April 9, 2026
SyntheticMR : Change of date for the Annual General Meeting in SyntheticMR AB (publ)
April 7, 2026
SyntheticMR: Change of date for the Annual General Meeting in SyntheticMR AB (publ)
April 7, 2026
SyntheticMR : rights issue has been registered – conversion of BTA into shares
February 11, 2026
SyntheticMR: SyntheticMR’s rights issue has been registered – conversion of BTA into shares
February 11, 2026
Sweden's SyntheticMR Q4 sales rise 42% yr/yr
February 6, 2026
SyntheticMR: SyntheticMR publishes the outcome of the rights issue
February 4, 2026
SyntheticMR : Today the subscription period commences in SyntheticMR AB’s rights issue
January 20, 2026
SyntheticMR: Today the subscription period commences in SyntheticMR AB’s rights issue
January 20, 2026
SyntheticMR: SyntheticMR AB publishes information document regarding the rights issue
January 19, 2026
SyntheticMR : Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR’s Position with a Broader Neuroimaging Offering
January 16, 2026
SyntheticMR: Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR’s Position with a Broader Neuroimaging Offering
January 16, 2026
SyntheticMR: SyntheticMR AB announces intention to publish financial guidance ahead of upcoming rights issue
January 15, 2026
SyntheticMR: Report from the extraordinary general meeting in SyntheticMR AB (publ)
January 9, 2026
SYNT: Q3 sales fell 7% with a large impairment, but strategic moves set up a Q4 growth rebound
November 28, 2025
SYNT: Sales grew 4% in Q2, but losses persisted; new CEO and acquisitions drive future growth
August 26, 2025
SYNT: Sales fell 20% in Q1 2025, but recurring revenue and cash flow showed improvement
May 20, 2025
SYNT: Sales fell sharply in 2024, but acquisitions and cost controls set up a 2025 turnaround
February 25, 2025
SYNT: Sales dropped 39% in Q3, but regulatory wins and new hires aim to restore growth
November 18, 2024
SYNT: Q2 sales fell sharply on North America weakness, but growth and new launches support future outlook
August 27, 2024